<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jing H</submitter><funding>HHS | NIH | National Institute on Drug Abuse</funding><pagination>e2112971118</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8522274</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>118(41)</volume><pubmed_abstract>Human genetic studies have pointed to a prominent role for innate immunity and lipid pathways in immunological and neurodegenerative disorders. Our understanding of the composition and function of immunomodulatory lipid networks in innate immune cells, however, remains incomplete. Here, we show that phospholipase Cγ2 (PLCγ2 or PLCG2)-mutations in which are associated with autoinflammatory disorders and Alzheimer's disease-serves as a principal source of diacylglycerol (DAG) pools that are converted into a cascade of bioactive endocannabinoid and eicosanoid lipids by DAG lipase (DAGL) and monoacylglycerol lipase (MGLL) enzymes in innate immune cells. We show that this lipid network is tonically stimulated by disease-relevant human mutations in PLCγ2, as well as Fc receptor activation in pri</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells.</pubmed_title><pmcid>PMC8522274</pmcid><funding_grant_id>DA037660</funding_grant_id><pubmed_authors>Jing H</pubmed_authors><pubmed_authors>Grigoleit JS</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Barbas S</pubmed_authors><pubmed_authors>Cravatt BF</pubmed_authors><pubmed_authors>Germain J</pubmed_authors><pubmed_authors>Herbst DM</pubmed_authors><pubmed_authors>Ulanovskaya OA</pubmed_authors><pubmed_authors>Henry CL</pubmed_authors><pubmed_authors>Masuda K</pubmed_authors><pubmed_authors>Reed A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells.</name><description>Human genetic studies have pointed to a prominent role for innate immunity and lipid pathways in immunological and neurodegenerative disorders. Our understanding of the composition and function of immunomodulatory lipid networks in innate immune cells, however, remains incomplete. Here, we show that phospholipase Cγ2 (PLCγ2 or PLCG2)-mutations in which are associated with autoinflammatory disorders and Alzheimer's disease-serves as a principal source of diacylglycerol (DAG) pools that are converted into a cascade of bioactive endocannabinoid and eicosanoid lipids by DAG lipase (DAGL) and monoacylglycerol lipase (MGLL) enzymes in innate immune cells. We show that this lipid network is tonically stimulated by disease-relevant human mutations in PLCγ2, as well as Fc receptor activation in pri</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-05T14:05:11.547Z</modification><creation>2025-04-05T14:05:11.547Z</creation></dates><accession>S-EPMC8522274</accession><cross_references><pubmed>34607960</pubmed><doi>10.1073/pnas.2112971118</doi></cross_references></HashMap>